Barclays analyst Saket Kalia reinstated coverage of Waystar (WAY) with an Overweight rating and $50 price target The firm believes consensus estimates look beatable into the company’s fiscal Q3 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAY:
- Waystar Completes Acquisition of Iodine Software
- Waystar joins S&P SmallCap 600 Index
- Waystar initiated with an Outperform at Citizens JMP
- Waystar Holding Corp.: Strategic Innovations and Market Opportunities Justify Buy Rating
- William Blair healthcare services analysts hold analyst/industry conference call